Related Experiment Video
Updated: Sep 14, 2025
07:01
Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
Published on: May 16, 2019
9.2K
"Targeting Neuroimmune Pathways in Epilepsy: Advances in Mechanisms and Emerging Therapeutics"
Manish Ravikumar1, Deenathayalan Uvarajan1, Brindha Durairaj2
1Department of Biochemistry, PSG College of Arts & Science, Coimbatore, India.
Neurochemical Research
|July 22, 2025
Summary
This study explores how immune system dysfunction and neuroinflammation contribute to epilepsy, focusing on glial cells and cytokines. It reviews new therapies targeting these pathways to reduce seizures and improve treatment.
Area of Science:
- Neuroimmunology
- Epileptology
- Neuroscience
Background:
- Immune system dysfunction and neuroinflammation are critical in epilepsy development and progression.
- Neuroinflammation significantly impacts neuronal integrity and seizure frequency.
- Understanding these interactions is key for treating immune-mediated neurological disorders.
Purpose of the Study:
- To investigate the intricate relationship between immune responses and epilepsy onset.
- To highlight the role of neuroinflammatory processes in epilepsy.
- To review novel therapeutic strategies targeting neuroinflammation for epilepsy treatment.
Main Methods:
- Review of scientific literature on neuroinflammation and epilepsy.
- Analysis of key factors: glial cell activation, pro-inflammatory cytokines, and blood-brain barrier (BBB) disruption.
- Examination of therapeutic approaches targeting neuroinflammatory pathways.
Main Results:
- Glial cell activation and pro-inflammatory cytokines are implicated in epilepsy.
- Blood-brain barrier disruption contributes to neuroinflammation in epilepsy.
- Novel therapies targeting neuroinflammation show potential for seizure reduction.
Conclusions:
- Neuroinflammation plays a significant role in epilepsy pathogenesis.
- Targeting neuroinflammatory pathways offers promising therapeutic avenues.
- Further research is needed to translate these findings into clinical practice for epilepsy.
Related Concept Videos
01:24Epilepsy and Seizures: Overview
284
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
284
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
659
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
659
01:14Antiepileptic Drugs: Glutamate Antagonists
519
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
519
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
454
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
454
01:20Antiepileptic Drugs: Potassium Channel Activators
280
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
280
01:08Antiepileptic Drugs: Sodium Channel Blockers
898
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
898